Ftse Mib
36.443,38
0,04%
DAX
21.732,05
0,01%
S&P 500
6.112,07
0,67%
NASDAQ
19.929,36
1,26%
Bitcoin
104.776,43
0,04%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ironwood Pharmaceuticals Inc (IRWD) Ironwood Pharmaceuticals Inc (IRWD) Notizie

Ironwood Pharmaceuticals Inc

IRWD
2,385
0,085 (3,70%)
Ultimo aggiornamento: 18:58:38
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/1/202523:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202523:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202523:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/1/202522:10EDGAR2Form 8-K - Current report
29/1/202522:05BWIronwood Pharmaceuticals Initiates Apraglutide NDA..
22/1/202523:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202522:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202522:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202422:43EDGAR2Form 144 - Report of proposed sale of securities
05/12/202423:00EDGAR2Form 8-K - Current report
26/11/202422:01BWIronwood Pharmaceuticals to Participate in the Piper Sandler..
20/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:10EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:07EDGAR2Form 144 - Report of proposed sale of securities
14/11/202421:31EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202422:01BWIronwood Pharmaceuticals to Participate in the Jefferies..
12/11/202422:05EDGAR2Form 8-K - Current report
07/11/202423:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:07EDGAR2Form 8-K - Current report
07/11/202413:00BWIronwood Pharmaceuticals Reports Third Quarter 2024 Results
28/10/202412:00BWOnce-Weekly Apraglutide Showed Consistent Treatment Effect..
24/10/202422:00BWIronwood Pharmaceuticals to Host Third Quarter 2024 Investor..
23/10/202423:04EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
30/9/202413:00EDGAR2Form 8-K - Current report
29/8/202422:01BWIronwood Pharmaceuticals to Participate in the 2024 Wells..
14/8/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:05EDGAR2Form 144 - Report of proposed sale of securities
08/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:07EDGAR2Form 8-K - Current report
08/8/202413:00BWIronwood Pharmaceuticals Reports Second Quarter 2024 Results
25/7/202422:00BWIronwood Pharmaceuticals to Host Second Quarter 2024..
12/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:57EDGAR2Form 144 - Report of proposed sale of securities
07/6/202419:35EDGAR2Form 144 - Report of proposed sale of securities
06/6/202421:57EDGAR2Form 144 - Report of proposed sale of securities
30/5/202422:01BWIronwood Pharmaceuticals to Participate in the Jefferies..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202412:00BWIronwood Late-Breaker Oral Presentation at Digestive Disease..
20/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:11EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:08EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:07EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:04EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 2,3907 Min: 2,33 Max: 2,54
Chiusura: 2,30

La tua Cronologia

NASDAQ
IRWD
Ironwood Pharmaceuticals
TG
KEQ0
ValOre Metals
BIT
FMQQ
Exchange Traded
BIT
UC3SB8
Unicredit Bank
BIT
UB6DC8
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci